Differential involvement of synaptic vesicle and presynaptic plasma membrane proteins in Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  1997-07-18

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1006/BBRC.1997.6940PMID 9240416
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fatty acylation of synaptotagmin in PC12 cells and synaptosomes.

  1996cited by this paper
• Common and distinct fusion proteins in axonal growth and transmitter release

  1996cited by this paper
• Developmental and plasticity‐related differential expression of two SNAP‐25 isoforms in the rat brain

  1996cited by this paper
• Synaptotagmin, a synaptic vesicle protein, is present in human cerebrospinal fluid: a new biochemical marker for synaptic pathology in Alzheimer disease?

  1996cited by this paper
• Insulin-responsive tissues contain the core complex protein SNAP-25 (synaptosomal-associated protein 25) A and B isoforms in addition to syntaxin 4 and synaptobrevins 1 and 2.

  1996cited by this paper
• Multiple palmitoylation of synaptotagmin and the t‐SNARE SNAP‐25

  1996cited by this paper
• Localization of synaptotagmin-binding domains on syntaxin

  1996cited by this paper
• Cellular and subcellular localization of syntaxin-like immunoreactivity in the rat striatum and cortex.

  1995cited by this paper
• HPC-1 is associated with synaptotagmin and omega-conotoxin receptor.

  1992cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  1991cited by this paper
• Domain structure of synaptotagmin (p65)

  1991cited by this paper
• Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease.

  1991cited by this paper
• Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

  1991cited by this paper
• Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease.

  1989cited by this paper
• Synaptobrevin: an integral membrane protein of 18,000 daltons present in small synaptic vesicles of rat brain.

  1989cited by this paper
• The identification of a novel synaptosomal-associated protein, SNAP-25, differentially expressed by neuronal subpopulations

  1989cited by this paper
• Alzheimer's disease.

  1986cited by this paper
• Protein p38: an integral membrane protein specific for small vesicles of neurons and neuroendocrine cells

  1986cited by this paper
• A marker of early amacrine cell development in rat retina.

  1985cited by this paper
• Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles.

  1985cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• An investigation on Alzheimer’s disease with obstructive sleep apnea: alterations of cognitive function, roles of cyclin-dependent kinase 5 and changes of brain structure

  2025cites this paper
• Investigation into Efficacy and Mechanisms of Neuroprotection of Ashwagandha Root Extract and Water-Soluble Coenzyme Q10 in a Transgenic Mouse Model of Alzheimer’s Disease

  2025cites this paper
• Synaptic biomarkers in the cerebrospinal fluid associate differentially with classical neuronal biomarkers in patients with Alzheimer’s disease and frontotemporal dementia

  2023cites this paper
• Integrative proteomics highlight presynaptic alterations and c-Jun misactivation as convergent pathomechanisms in ALS

  2023cites this paper
• An astrocyte-derived cytokine TIMP-1 restores synaptic plasticity in an Alzheimer’s disease model

  2023cites this paper
• Astroglia-derived TIMP-1 alleviates cognitive deficits by restoring synaptic plasticity in Alzheimer’s disease

  2023cites this paper
• Damaged mitochondria coincide with presynaptic vesicle loss and abnormalities in alzheimer’s disease brain

  2023cites this paper
• Increased levels of the synaptic proteins PSD-95, SNAP-25, and neurogranin in the cerebrospinal fluid of patients with Alzheimer’s disease

  2022cites this paper
• Cerebrospinal Fluid Synaptosomal-Associated Protein 25 Levels in Patients with Alzheimer’s Disease: A Meta-Analysis

  2022cites this paper
• Copolymer-1 as a potential therapy for mild cognitive impairment.

  2022cites this paper
• Functional and pathological effects of α-synuclein on synaptic SNARE complexes.

  2022cites this paper
• Dysfunction of the SNARE complex in neurological and psychiatric disorders.

  2021cites this paper
• Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives

  2021cites this paper
• MicroRNA-153 impairs presynaptic plasticity by blocking vesicle release following chronic brain hypoperfusion

  2020cites this paper
• Utility of Animal Models to Understand Human Alzheimer’s Disease, Using the Mastermind Research Approach to Avoid Unnecessary Further Sacrifices of Animals

  2020cites this paper
• Systems biology reveals reprogramming of the S-nitroso-proteome in the cortical and striatal regions of mice during aging process

  2020cites this paper
• The role of synaptic biomarkers in the spectrum of neurodegenerative diseases

  2020cites this paper
• Clinical Utility of the Pathogenesis-Related Proteins in Alzheimer’s Disease

  2020cites this paper
• Serum miRNAs Expression and SNAP-25 Genotype in Alzheimer’s Disease

  2019cites this paper
• Network Analysis of a Membrane-Enriched Brain Proteome across Stages of Alzheimer’s Disease

  2019cites this paper
• SNAP-25 in Serum Is Carried by Exosomes of Neuronal Origin and Is a Potential Biomarker of Alzheimer’s Disease

  2019cites this paper
• Anandamide Effects in a Streptozotocin-Induced Alzheimer’s Disease-Like Sporadic Dementia in Rats

  2018cites this paper
• APOE ε4 is associated with higher levels of CSF SNAP-25 in prodromal Alzheimer's disease.

  2018cites this paper
• Génération de cellules souches pluripotentes induites de patients Alzheimer et production d'un modèle de culture en trois dimensions de neurones pour les recherches diagnostiques et thérapeutiques de la maladie d’Alzheimer

  2018cites this paper
• Association of Neuropathological Markers in the Parietal Cortex With Antemortem Cognitive Function in Persons With Mild Cognitive Impairment and Alzheimer Disease

  2017cites this paper
• Effect of APOE Genotype on Synaptic Proteins in Earlier Adult Life

  2017cites this paper
• Catalpol protects synaptic proteins from beta-amyloid induced neuron injury and improves cognitive functions in aged rats

  2017cites this paper
• Synaptic Vesicle-Recycling Machinery Components as Potential Therapeutic Targets

  2017cites this paper
• The iTRAPs: Guardians of Synaptic Vesicle Cargo Retrieval During Endocytosis

  2016cites this paper
• Synaptic protein levels altered in vascular dementia

  2015cites this paper
• Neurodegeneration in Amygdala Precedes Hippocampus in the APPswe/ PS1dE9 Mouse Model of Alzheimer's Disease.

  2015cites this paper
• Opposing effects of APP/PS1 and TrkB.T1 genotypes on midbrain dopamine neurons and stimulated dopamine release in vivo.

  2015cites this paper
• Targeting Synaptic Pathology with a Novel Affinity Mass Spectrometry Approach*

  2014cites this paper
• SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease

  2014cites this paper
• Gene-based GWAS and biological pathway analysis of the resilience of executive functioning

  2013cites this paper
• Vitamin E prevents hyperoxia-induced loss of soluble N-ethylmaleimide-sensitive fusion protein attachment protein receptor proteins in the rat neuronal cytoplasm.

  2013cites this paper
• Analysis of SNAP25 mRNA expression and promoter DNA methylation in brain areas of Alzheimer's Disease patients.

  2012cites this paper
• Vitamin E Inhibits Oxidative Stress-Induced Denaturation of Nerve Terminal Proteins Involved in Neurotransmission

  2012cites this paper
• Neuropathology of Alzheimer's Disease and its Variants

  2011cites this paper
• Mild cognitive impairment: pathology and mechanisms

  2011cites this paper
• Network-Based Elucidation of Human Disease Similarities Reveals Common Functional Modules Enriched for Pluripotent Drug Targets

  2010cites this paper
• Uncovering Molecular Biomarkers That Correlate Cognitive Decline with the Changes of Hippocampus' Gene Expression Profiles in Alzheimer's Disease

  2010cites this paper
• Neuropathologie morphologique et molculaire de la maladie dAlzheimer

  2009cites this paper
• Target Identification for CNS Diseases by Transcriptional Profiling

  2009cites this paper
• Synaptic degeneration in Alzheimer’s disease

  2009cites this paper
• Spatial organisation of the SNARE proteins: the role of munc18-1

  2009cites this paper
• [Morphologic and molecular neuropathology of Alzheimer's disease].

  2009cites this paper
• Classification and basic pathology of Alzheimer disease

  2009cites this paper
• The developmental potential of the C. elegans RFX transcription factor DAF-19

  2009cites this paper
• Inhibition of SNAP25 expression by HIV‐1 Tat involves the activity of mir‐128a

  2008cites this paper
• Antagonizing β-amyloid peptide neurotoxicity of the anti-aging fungus Ganoderma lucidum

  2008cites this paper
• Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease.

  2008cites this paper
• Loss of synaptophysin and synaptosomal‐associated protein 25‐kDa (SNAP‐25) in elderly Down syndrome individuals

  2007cites this paper
• Matrix metalloproteinase-7 modulates synaptic vesicle recycling and induces atrophy of neuronal synapses.

  2007cites this paper
• Modulation of adult neural plasticity by proteolytic catabolism of lecticans

  2007cites this paper
• Expression of Vascular Endothelial Growth Factor and Its Receptors in the Central Nervous System in Amyotrophic Lateral Sclerosis

  2006cites this paper
• Single cell gene expression profiling in Alzheimer’s disease

  2006cites this paper
• A radioassay for synaptic core complex assembly: screening of herbal extracts for effectors.

  2006cites this paper
• Differential Expression of Synaptic Proteins in the Frontal and Temporal Cortex of Elderly Subjects With Mild Cognitive Impairment

  2006cites this paper
• Influence of oxidative stress on fusion of pre-synaptic plasma membranes of the rat brain with phosphatidyl choline liposomes, and protective effect of vitamin E.

  2006cites this paper
• Les transporteurs vésiculaires du glutamate, VGLUT1 et VGLUT2, dans les maladies de Parkinson et d'Alzheimer

  2006cites this paper
• Regional alteration of synapsin I in the hippocampal formation of Alzheimer’s disease patients

  2004cites this paper
• Regional and progressive changes in brain expression of complexin II in a mouse transgenic for the Huntington's disease mutation.

  2004cites this paper
• Neuropathology of Alzheimer’s Disease, as Seen in Fixed Tissues

  2004cites this paper
• Aging potentiates Aβ-induced depletion of SNAP-25 in mouse hippocampus

  2003cites this paper
• Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the 'Dr. Jekyll and Mr. Hyde concept' of Alzheimer's disease or the yin and yang of neuroplasticity.

  2003cites this paper
• Possible involvement of Wiskott-Aldrich syndrome protein family in aberrant neuronal sprouting in Alzheimer's disease.

  2003cites this paper
• Pathology of presynaptic proteins in Alzheimer's disease: more than simple loss of terminals.

  2003cites this paper
• Le diagnostic : de la neuropathologie à l’imagerie cérébrale

  2002cites this paper
• Reversal of amyloid β toxicity in Alzheimer's disease model Tg2576 by intraventricular antiamyloid β antibody

  2002cites this paper
• Detection and Analysis of Synaptosis

  2002cites this paper
• Animal model of dementia induced by entorhinal synaptic damage and partial restoration of cognitive deficits by BDNF and carnitine

  2002cites this paper
• Changes in monocyte/macrophage neurotoxicity in the era of HAART: implications for HIV-associated dementia

  2002influential citation
• Reversal of amyloid beta toxicity in Alzheimer's disease model Tg2576 by intraventricular antiamyloid beta antibody.

  2002cites this paper
• Abnormalities of SNARE mechanism proteins in anterior frontal cortex in severe mental illness.

  2002cites this paper
• Differential expression between synaptic vesicle proteins and presynaptic plasma membrane proteins in the anterior horn of amyotrophic lateral sclerosis

  2002cites this paper
• Staring, a Novel E3 Ubiquitin-Protein Ligase That Targets Syntaxin 1 for Degradation*

  2002cites this paper
• Synaptic Pathology in Prefrontal Cortex is Present Only with Severe Dementia in Alzheimer Disease

  2001cites this paper
• Abnormalities in the synaptic vesicle fusion machinery in Huntington's disease.

  2001cites this paper
• Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization.

  2001cites this paper
• Synaptosomal Proteins, Beta-Soluble N-Ethylmaleimide-Sensitive Factor Attachment Protein (Beta-SNAP), Gamma-SNAP and Synaptotagmin I in Brain of Patients with Down Syndrome and Alzheimer’s Disease

  2001cites this paper
• Distribution of chromogranin B-like immunoreactivity in the human hippocampus and its changes in Alzheimer’s disease

  2000cites this paper
• Expression profile of transcripts in Alzheimer's disease tangle‐bearing CA1 neurons

  2000cites this paper
• Prion protein expression in senile plaques in Alzheimer's disease

  2000cites this paper
• Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer's disease brains.

  2000cites this paper
• Maladie d'Alzheimer : les lésions et leur progression

  1999cites this paper
• Loss of proteins regulating synaptic plasticity in normal aging of the human brain and in Alzheimer disease.

  1999cites this paper
• Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down Syndrome and Alzheimer's disease

  1999cites this paper
• Variations of synaptotagmin I, synaptotagmin IV, and synaptophysin mRNA levels in rat hippocampus during the estrous cycle.

  1999cites this paper
• Autoradiographic comparison of [3H](−)nicotine, [3H]cytisine and [3H]epibatidine binding in relation to vesicular acetylcholine transport sites in the temporal cortex in Alzheimer's disease

  1999cites this paper
• Nutrition and neurodevelopment: mechanisms of developmental dysfunction and disease in later life

  1999cites this paper
• Differential expression of rat brain synaptic proteins in development and aging.

  1998cites this paper
• Spot the difference : microarray analysis of gene expression changes in Alzheimer ’ s and Parkinson ’ s Disease

  year unknowncites this paper